Neurocognitive performance and negative symptoms: Are they equal in explaining disability in schizophrenia outpatients?

被引:65
|
作者
Villalta-Gil, Victoria
Vilaplana, Miriam
Ochoa, Susana
Haro, Josep Maria
Dolz, Montserrat
Usall, Judit
Cervilla, Jorge
机构
[1] St Joan Deu Serv Salud Mental, Fundac St Joan Deu, Res & Dev Unit, Barcelona 08830, Spain
[2] Univ Granada, Inst Neurosci, Granada, Spain
关键词
schizophrenia; psychopathology; Positive and Negative Syndrome Scale (PANSS); cognitive functioning; disability;
D O I
10.1016/j.schres.2006.06.013
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The aim of this study is to assess if cognitive variables and symptom dimensions can predict disability in a sample of outpatients with schizophrenia. Method: A cross-sectional sample of 113 individuals with a diagnosis of schizophrenia (DSM-IV criteria) was selected from a computerized register of five Community Mental Health Centers. Patients were assessed by two trained psychologists, with a neuropsychological battery comprising measures for verbal memory, attention, operative memory and abstraction and flexibility functions. Symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS); a socio-demographic and clinical questionnaire, comprising the Disability Assessment Scale (DAS), was also completed. Test scores were standardized (t scores) to performance of healthy controls. To assess the relationship between clinical and sociodemographic factors and disability and cognitive functioning Pearson's correlation coefficients were computed. In order to establish the predictive capacity of the cognitive, clinical and symptom variables on disability linear regression models were fitted. Results: Mean age of patients was 41.6 years and 68% were male. Higher ratings in the negative dimension were associated with more cognitive deficits. Association with the positive dimension was present but less strong. All disability areas, except for disability in occupational functioning, were partially explained by the negative dimension. Disability in family functioning was also partially explained by attention and number of admissions since onset. Conclusion: Negative symptoms are the major source of disability of our sample and are also associated to cognitive functioning. The present findings suggest that further investigation on the mediators between clinical and social outcomes may help to design specific treatments to reduce disability. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 50 条
  • [21] NEGATIVE SYMPTOMS AND SOCIAL SKILLS PERFORMANCE IN SCHIZOPHRENIA
    JACKSON, HJ
    MINAS, IH
    BURGESS, PM
    JOSHUA, SD
    CHARISIOU, J
    CAMPBELL, IM
    [J]. SCHIZOPHRENIA RESEARCH, 1989, 2 (06) : 457 - 463
  • [22] NEGATIVE SYMPTOMS AND NEUROCOGNITIVE DEFICITS IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER
    Chang, W. C.
    Hui, L. M.
    Lam, M. L.
    Chan, K. W.
    Wong, H. Y.
    Tang, Y. M.
    Chen, Y. H.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 240 - 240
  • [23] Cognitive dysfunction among inpatients and outpatients with schizophrenia: relationship to positive and negative symptoms
    Tarek Ahmed Okasha
    Hanan Hussein
    Eman Shorub
    Hamed Nagi
    Ahmed A. Moustafa
    Doha El-Serafi
    [J]. Middle East Current Psychiatry, 27
  • [24] Cognitive dysfunction among inpatients and outpatients with schizophrenia: relationship to positive and negative symptoms
    Okasha, Tarek Ahmed
    Hussein, Hanan
    Shorub, Eman
    Nagi, Hamed
    Moustafa, Ahmed A.
    El-Serafi, Doha
    [J]. MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH, 2020, 27 (01):
  • [25] Negative symptoms of schizophrenia-critical target to reduce functional disability?
    Rao, Naren P.
    Indla, Vishal
    Behere, Rishikesh V.
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (05) : S19 - S20
  • [26] Olanzapine versus Risperidone:: Efficacy results in negative symptoms of a one year randomized trial in outpatients with schizophrenia with prominent negative symptoms
    Olivares, JM
    Ciudad, A
    Gomez, JC
    Cuesta, M
    Bousoño, M
    Alvarez, E
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S407 - S407
  • [27] Negative expectancy appraisals and defeatist performance beliefs and negative symptoms of schizophrenia
    Couture, Shannon M.
    Blanchard, Jack J.
    Bennett, Melanie E.
    [J]. PSYCHIATRY RESEARCH, 2011, 189 (01) : 43 - 48
  • [28] Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia
    Marx, Christine E.
    Keefe, Richard S.
    Leimone, Linda A.
    Hamer, Robert M.
    Bradford, Daniel W.
    Dunn, Lawrence
    Payne, Victoria M.
    Naylor, Jennifer C.
    Savitz, Adam J.
    Strauss, Jennifer L.
    Lieberman, Jeffrey A.
    Shampine, Lawrence J.
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 13S - 13S
  • [29] POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - ATTENTIONAL PERFORMANCE CORRELATES
    WALKER, E
    HARVEY, P
    [J]. PSYCHOPATHOLOGY, 1986, 19 (06) : 294 - 302
  • [30] NEUROPSYCHOLOGICAL PERFORMANCE IN SCHIZOPHRENIA - RELATION TO POSITIVE AND NEGATIVE SYMPTOMS
    OLEARY, DS
    ANDREASEN, NC
    ARNDT, S
    KESLER, MI
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1991, 13 (01) : 99 - 99